1. Abdel-Rahman, S. M., K. Marcucci, T. Boge, R. R. Gotschall, G. L. Kearns, and J. S. Leeder. 1999. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine. Drug Metab. Dispos.27:770-775.
2. Adams, H. R., E. L. Isaacson, and B. S. Masters. 1977. Inhibition of hepatic microsomal enzymes by chloramphenicol. J. Pharmacol. Exp. Ther.203:388-396.
3. Bajpai, M., L. K. Roskos, D. D. Shen, and R. H. Levy. 1996. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab. Dispos.24:1401-1403.
4. Bui, L., and D. D. Huang. 1999. Possible interaction between cyclosporine and chloramphenicol. Ann. Pharmacother.33:252-253.
5. Desta, Z., X. Zhao, J. G. Shin, and D. A. Flockhart. 2002. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin. Pharmacokinet.41:913-958.